2-176107587-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_021192.3(HOXD11):c.232G>A(p.Gly78Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000064 in 1,374,716 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_021192.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000606 AC: 9AN: 148490Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000973 AC: 11AN: 113104Hom.: 0 AF XY: 0.000122 AC XY: 8AN XY: 65400
GnomAD4 exome AF: 0.0000644 AC: 79AN: 1226136Hom.: 0 Cov.: 32 AF XY: 0.0000736 AC XY: 44AN XY: 597574
GnomAD4 genome AF: 0.0000606 AC: 9AN: 148580Hom.: 0 Cov.: 32 AF XY: 0.0000414 AC XY: 3AN XY: 72528
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 26, 2023 | The c.232G>A (p.G78S) alteration is located in exon 1 (coding exon 1) of the HOXD11 gene. This alteration results from a G to A substitution at nucleotide position 232, causing the glycine (G) at amino acid position 78 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at